Cyclo Therapeutics Inc.

NASDAQ: CYTH · Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM

Cyclo Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.08M 1.38M 1.59M
Cost of Revenue
98.46K 138.93K 156.08K
Gross Profit
977.95K 1.24M 1.43M
Operating Income
-20.05M -15.61M -14.27M
Interest Income
n/a 12.47K 3.4K
Pretax Income
-20.06M -15.45M -14.29M
Net Income
-20.06M -15.28M -14.31M
Selling & General & Admin
5.67M 7.82M 6.52M
Research & Development
14.18M 9M 9.15M
Other Expenses
n/a 30.5K 27.54K
Operating Expenses
21.04M 16.85M 15.7M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
3.9K 13.06K 18.34K
Cost & Expenses
21.13M 16.99M 15.85M
Income Tax Expense
n/a -171K 18.52K
Shares Outstanding (Basic)
16.33M 8.44M 6.37M
Shares Outstanding (Diluted)
16.33M 8.44M 6.37M
EPS (Basic)
-1.23 -1.81 -2.25
EPS (Diluted)
-1.23 -1.81 -2.25
EBITDA
-20.03M -15.6M -14.27M
EBIT
-20.05M -15.61M -14.27M
Depreciation & Amortization
19.28K 19.48K 16.83K